GlaxoSmithKline (GSK) - Stock Analysis
GlaxoSmithKline (GSK) - Stock Analysis

GlaxoSmithKline (GSK) - Stock Analysis

Maemma

21 min
Business & Finance
Play

Description

<p>Back in action, in this weeks episode of the Bank On Dividends Podcast, Banky takes a deeper look into the Pharmaceutical giant &nbsp;Glaxo Smith Kline: Ticker &nbsp;"GSK". Established in 2000 by a merger of Glaxo Wellcome and SmithKline Beecham, GSK was the world's sixth-largest pharmaceutical company. &nbsp;In August 2016, it had a market capitalisation of £81&nbsp;billion (about US$107&nbsp;billion), the fourth largest on the London Stock Exchange. But is GSK a stock to consider when building a portfolio you can bank on!<br> <br> Follow on Instagram and Twitter @BankOnDividends</p> <p>https://linktr.ee/BankOnDividends</p> <p>Use the above link for a free share &amp; Also support the Podcast with a one-time donation!</p> <p>Thank You All!</p>

Uploader

wade_stream

wade_stream

GlaxoSmithKline (GSK) - Stock Analysis - Listen Free | WowFM